近日，清华大学玉泉医院马羽团队正式发布"病-脑-身"三维一体诊疗体系，这一创新框架将推动帕金森 病诊疗从单一症状治疗迈向系统化、精准化的全新阶段。 众所周知，在帕金森病诊疗领域，患者常常陷入这样的困境：症状描述模糊导致治疗被动，药物疗效波 动让生活质量难以保障。面对这些难题，清华大学玉泉医院马羽团队迎难而上，经过二十年的深耕不 辍，通过对千余例脑深部电刺激术（DBS）患者的长期随访和系统研究，逐步揭示了传统诊疗模式的局 限性。 该团队发现，单纯依赖药物调整或手术干预，往往难以实现患者获益最大化。马羽教授在临床工作中深 刻体会到："帕金森病是一个涉及多系统、多层次的复杂疾病，需要更系统化的诊疗方案。"这一认识促 使她带领团队开始构建全新的诊疗框架。 三是在"身"的维度，团队引入中医整体观，建立了症候评估与调理体系。通过调和气血、平衡阴阳，改 善患者整体机能状态，实现了"脑-身"功能的协同优化。 该体系在临床应用中展现出三大显著优势。一是通过多维度评估，实现了诊断精准化；二是基于三维数 据制定的个性化治疗方案，推动治疗从"经验用药"转向"数据驱动"；三是建立的全程化管理模式，确保 了治疗效果的持续优化。 尤为值得 ...

Core Viewpoint - The article highlights the significant milestone achieved by United Imaging Healthcare with the approval and launch of its uSONIQUE series of color Doppler ultrasound diagnostic systems, marking a transition from high-end imaging equipment manufacturing to a comprehensive intelligent diagnostic platform [1][5][25]. Summary by Sections Product Approval and Launch - On November 11, 2025, United Imaging's subsidiary received three medical device registration certificates from the National Medical Products Administration (NMPA) for its self-developed color Doppler ultrasound diagnostic systems [1][5]. - The subsequent global ultrasound product launch occurred on November 12, showcasing the uSONIQUE series, which took six years to develop [1][5]. Product Range and Market Coverage - The approved ultrasound systems include three series: uSONIQUE Pulse (ultra-high-end), uSONIQUE Genesis (high-end), and uSONIQUE Venus (mid-range/economic), creating a complete market coverage matrix [3][5]. - These products are applicable in various clinical scenarios, including cardiology, obstetrics, and emergency care [3]. Technological Innovations - The uSONIQUE series is built on the uEDGETEC intelligent perception technology platform, integrating AI throughout the hardware and algorithmic processes [8]. - Key innovations include the AIClear real-time intelligent noise reduction algorithm, which significantly improves imaging quality for challenging patients [12]. - The AIStream workflow automates the entire process from probe activation to report generation, reducing scan time by approximately 88% [14]. Strategic Significance - The launch of the ultrasound business is seen as a crucial addition to United Imaging's "imaging-diagnosis integration ecosystem," completing its portfolio that already includes CT, MRI, and PET technologies [20][22]. - The company aims to enhance its international competitiveness and fill the gap in the high-frequency, high-resolution imaging market, where domestic market penetration is currently low [23][24]. Global Expansion Plans - United Imaging plans to unveil the global version of the uSONIQUE series at the 2025 RSNA conference, accelerating its FDA certification and market expansion in Europe and the U.S. [24]. - The company leverages its established global brand and channel resources to lead the domestic high-end ultrasound market [23].

Core Viewpoint - The third National Postdoctoral Innovation and Entrepreneurship Competition has launched a "Challenge and Lead" project list, featuring 766 technology projects that seek participation from postdoctoral researchers and teams [1][2]. Group 1: Competition Overview - The competition is the largest and most comprehensive postdoctoral event in China, aimed at promoting the integration of industry, academia, and research [1]. - The "Challenge and Lead" segment invites enterprises to present technical challenges, which postdoctoral researchers are encouraged to solve [1]. Group 2: Project Details - A total of 766 project demands have been released, focusing on four key areas aligned with national strategies and cutting-edge scientific technologies, with a total planned investment exceeding 40 billion yuan [2]. - The projects cover seven major directions, including new generation information technology and artificial intelligence, high-end equipment manufacturing, and robotics [2]. - The top areas of demand include: - New generation information technology and artificial intelligence: 143 projects (18.7%) - Biomedicine and health: 140 projects (18.3%) - New materials and petrochemicals: 135 projects (17.6%) - High-end equipment manufacturing and robotics: 131 projects (17.1%) - New energy and energy conservation: 93 projects (12.1%) - Modern agriculture and food: 67 projects (8.7%) - Other industries: 57 projects (7.4%) [2]. Group 3: Participation and Timeline - The project list has been publicly released on various platforms, including the China Postdoctoral website and the official competition website [3]. - The registration deadline for participation is July 31, 2025, with successful teams invited to the finals in Quanzhou, Fujian Province, in mid to late October [3].